Xuan Wu hospitial, capical medical university
Beijing, China
NCT Number: NCT06097013
The research focuses on establishing a system for detecting loss of consciousness, developing clinical prognostic and awakening-related brain function testing criteria.
Interested in participating?
Request Info14 year–60 year
All sexes
Observational
Beijing, China
A framework for the acquisition of neural features, feature selection and mechanism analysis of consciousness deficits in patients with acute and prolonged disorders of consciousness(DOC). Based on the multimodal data of three types of patients with DOC, the investigators established a comprehensive scientific collection of brain function features of acute and prolonged consciousness disorders; Revealed the key neural nodes and circuits of consciousness deficits, and elucidated the neural mechanisms of consciousness deficits in patients with prolonged consciousness disorders from EEG time-frequency-spatial features;
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Admission criteria for patients with prolonged disorders of consciousness
Inclusion criteria
Exclusion criteria
Admission criteria for patients with acute disorders of consciousness
Inclusion criteria
(1)Age 14-60 years; (2)Meets diagnostic criteria for coma recognized in international studies; (3)the GCS score was less than 8; (4)Brain Trauma, stroke and hypoxic-ischemic encephalopathy lead to disturbance of consciousness; (5) right-handed; (6)The patient's family members signed the informed consent form;
Exclusion criteria
Routine clinical rehabilitation
Time frame: Within 24 hours of enrollment
CRS-R scale includes 6 dimensions such as audiovisual, arousal level, verbal response, motor and communication, scoring 0 to 23, the higher the score the better the neurological function, and each score reflects the presence or absence of the evaluated person and the strength of consciousness
Time frame: Assessment within 24 hours before, and 1 hour after TMS treatment
Assessment the p300 in event related potential(ERP)
Time frame: Assessment within 24 hours before, and 1 hour after TMS treatment
Assessment the spectral power and coherence by in resting-state EEG
Time frame: Assessment within 24 hours before, and 1 hour after TMS treatment
Assessment the TMS Evoked Potential(TEP)
Time frame: Assessment within 24 hours before, and 1 hour after TMS treatment
Assessment the perturbational complexity index(PCI) in TMS-EEG
Time frame: Assessment within 24 hours before ,and 1 hour after TMS treatment
The distribution of 18F-FDG in the brain was analyzed according to the imaging situation, and the brain regions of interest (ROI) were outlined, and the uptake of 18F-deoxyglucose (FDG) in the patients was observed according to the brain ROI.
Xuanwu Hospital, Beijing
Other
Science and Technology Innovation 2030
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07074678
Brain Damage, Chronic, Brain Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT05682248
Consciousness Disorders, Disorder of Consciousness
Beijing, China
View Trial DetailsNCT07551076
Consciousness Disorders, Disorder of Consciousness
View Trial DetailsNCT07699055
Consciousness Disorders, Disorder of Consciousness
Istanbul, Bağcılar, Turkey (Türkiye)
View Trial Details